Prime Medicine Inc (NASDAQ: PRME) Could Achieve Gains In The Near Future

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Prime Medicine Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Prime Medicine Inc is $799.40M. A total of 0.84 million shares were traded on the day, compared to an average of 798.54K shares.

In the most recent transaction, ARCH Venture Partners XII, LLC bought 3,200,000 shares of PRME for 6.25 per share on Feb 15 ’24. After the transaction, the 10% Owner now owns 3,200,000 company shares. In a previous transaction on Feb 15 ’24, ARCH Venture Partners X, LLC bought 3,200,000 shares at 6.25 per share. PRME shares that 10% Owner owns now total 3,200,000.

Among the insiders who bought shares, NELSEN ROBERT acquired of 3,200,000 shares on Feb 15 ’24 at a per-share price of $6.25. This resulted in the Director holding 3,200,000 shares of PRME after the transaction. In another insider transaction, GV 2019 GP, L.L.C. sold 19,003 shares at $14.97 per share on Jun 21 ’23. Company shares held by the 10% Owner now total 0.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PRME has a high of $17.20 and a low of $4.11.

As of this writing, PRME has an earnings estimate of -$0.41 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.47 in the last quarter

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PRME’s latest balance sheet shows that the firm has $269.62M in Cash & Short Term Investments as of fiscal 2021. There were $10.41M in debt and $57.98M in liabilities at the time. Its Book Value Per Share was $2.03, while its Total Shareholder’s Equity was $239.56M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRME is Buy with a score of 4.27.

Most Popular

Related Posts